GlassScriptPhysician profile
Nicole Mcgraw
NPI 1649610262
$832.24
in general payments reported to CMS, 2019-2025
22 companies · $14.52 in 2025
The $14.52 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2020: $132 · 2021: $144 · 2022: $200 · 2023: $124 · 2024: $103 · 2025: $14.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $241.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $198.76 | 2019-2023 | |
| Daiichi Sankyo INC. | $69.94 | 2019-2022 | |
| Applied Medical Resources Corporation | $65.96 | 2022 | |
| Aspira Women'S Health INC | $49.35 | 2020-2021 | |
| Minerva Surgical, INC | $45.02 | 2021 | |
| Biogen, INC. | $44.49 | 2024 | Zurzuvae |
| Pfizer INC. | $43.28 | 2020-2022 | |
| Hologic Sales and Service, LLC | $43.08 | 2022-2023 | Acessa Provu System |
| Exeltis, USA INC. | $40.77 | 2023 | Slynd |
| Astellas Pharma US INC | $36.86 | 2024 | Veozah |
| Therapeuticsmd, INC. | $25.47 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.58 | 2019-2020 | |
| Myovant Sciences INC. | $23.48 | 2022 | |
| Coopersurgical, INC. | $21.85 | 2024 | Paragard T 380a |
| Mayne Pharma Commercial LLC | $17.77 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $16.43 | 2019 | |
| Lilly USA, LLC | $14.52 | 2025 | Zepbound, Mounjaro |
| Mylan Pharmaceuticals INC. | $13.46 | 2021 | |
| Roche Diagnostics Corporation | $12.19 | 2019 | |
| Amag Pharmaceuticals, INC. | $11.09 | 2019 | |
| Merck Sharp & Dohme LLC | $11.00 | 2019 | |
| Alydia Health | $3.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Mcgraw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.